James C. Paulson

Q: What Schools Are Affiliated With James C. Paulson

James C. Paulson is affiliated with the following schools: Duke University, University of Calgary, MacMurray College, University of California, Berkeley, University of Erlangen–Nuremberg, University of Alberta, Louisiana State University, University of New Hampshire, University of California, San Diego, University of California, Los Angeles, Rockefeller University, University of Illinois Urbana-Champaign

James C. Paulson's AcademicInfluence.com Rankings

James C. Paulson

Biology

#2368

World Rank

#3770

Historical Rank

#1063

USA Rank

Biochemistry

#393

World Rank

#467

Historical Rank

#150

USA Rank

biology Degrees

Download Badge

Biology

James C. Paulson's Degrees

PhD Biochemistry University of California, Berkeley
Bachelors Chemistry University of California, Berkeley

Why Is James C. Paulson Influential?

(Suggest an Edit or Addition)

According to Wikipedia, James C. Paulson is an American biochemist and biologist known for his work in glycobiology. Career A graduate of MacMurray College and University of Illinois at Urbana–Champaign , Paulson was a faculty member and vice-chair of the Department of Biological Chemistry at UCLA School of Medicine from 1978-1990. In 1996, he began working for Cytel Corporation, where he was vice president, chief scientific officer, and member of the Board of Directors.

(See a Problem?)

James C. Paulson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Siglecs and their roles in the immune system (2007) (1597)
ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. (1990) (1242)
New World Bats Harbor Diverse Influenza A Viruses (2013) (1168)
Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid (1988) (1082)
Molecular Basis for the Generation in Pigs of Influenza A Viruses with Pandemic Potential (1998) (1038)
Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. (2004) (1019)
Structure and Receptor Specificity of the Hemagglutinin from an H5N1 Influenza Virus (2006) (944)
Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. (1983) (908)
Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. (1989) (818)
Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. (1994) (812)
Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc (2008) (762)
Symbol Nomenclature for Graphical Representations of Glycans. (2015) (693)
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield (2011) (691)
Siglec-mediated regulation of immune cell function in disease (2014) (687)
Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity (1983) (659)
Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. (2006) (606)
Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. (1992) (465)
Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. (1993) (456)
CD62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x. (1991) (453)
Glycoproteins: what are the sugar chains for? (1989) (439)
Demonstration of an extensive trans-tubular network continuous with the Golgi apparatus stack that may function in glycosylation (1985) (409)
Glycomics: an integrated systems approach to structure-function relationships of glycans (2005) (402)
Characterization of H7N9 influenza A viruses isolated from humans (2013) (392)
Neutrophil-dependent acute lung injury. Requirement for P-selectin (GMP-140). (1992) (378)
Synthesis of sugar arrays in microtiter plate. (2002) (376)
Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. (1993) (376)
Glycan microarrays for decoding the glycome. (2011) (364)
Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers. (2014) (350)
Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. (1994) (341)
Sweet spots in functional glycomics (2006) (334)
Immune regulation by the ST6Gal sialyltransferase. (1998) (332)
High-efficiency labeling of sialylated glycoproteins on living cells (2009) (331)
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120 (2013) (329)
Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers. (2014) (329)
Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome. (2012) (317)
Primary structure of beta-galactoside alpha 2,6-sialyltransferase. Conversion of membrane-bound enzyme to soluble forms by cleavage of the NH2-terminal signal anchor. (1987) (316)
Glycan microarray technologies: tools to survey host specificity of influenza viruses (2006) (306)
Protective effects of oligosaccharides in P-selectin-dependent lung injury (1993) (291)
Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans (2013) (283)
Cell surface biology mediated by low affinity multivalent protein-glycan interactions. (2004) (282)
Purification and properties of sialoadhesin, a sialic acid‐binding receptor of murine tissue macrophages. (1991) (273)
Influenza C virus uses 9-O-acetyl-N-acetylneuraminic acid as a high affinity receptor determinant for attachment to cells. (1986) (273)
Replication and Transmission of H9N2 Influenza Viruses in Ferrets: Evaluation of Pandemic Potential (2008) (272)
Alteration of terminal glycosylation sequences on N-linked oligosaccharides of Chinese hamster ovary cells by expression of beta-galactoside alpha 2,6-sialyltransferase. (1989) (260)
Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein (2017) (256)
Specific gangliosides function as host cell receptors for Sendai virus. (1981) (250)
A General Strategy for the Chemoenzymatic Synthesis of Asymmetrically Branched N-Glycans (2013) (243)
Differential expression of five sialyltransferase genes in human tissues. (1994) (242)
Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking (2005) (240)
Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2. (1982) (234)
Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity. (1990) (217)
Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity. (2008) (206)
Cloning of a novel alpha 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups. (1994) (206)
Differential sensitivity of human, avian, and equine influenza A viruses to a glycoprotein inhibitor of infection: selection of receptor specific variants. (1983) (202)
In vivo behavior of neutrophils from two patients with distinct inherited leukocyte adhesion deficiency syndromes. (1993) (199)
Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility (2008) (199)
Sialoside Specificity of the Siglec Family Assessed Using Novel Multivalent Probes (2003) (197)
Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury. (1993) (192)
In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity. (2012) (190)
The Sialyltransferase Sialylmotif Participates in Binding the Donor Substrate CMP-NeuAc (*) (1995) (188)
The receptor‐binding and membrane‐fusion properties of influenza virus variants selected using anti‐haemagglutinin monoclonal antibodies. (1987) (185)
In vivo targeting of B-cell lymphoma with glycan ligands of CD22. (2010) (183)
Erythrocyte receptors for Mycoplasma pneumoniae are sialylated oligosaccharides of Ii antigen type (1984) (182)
Siglecs as targets for therapy in immune-cell-mediated disease. (2009) (181)
Sialyl- and fucosyltransferases in the biosynthesis of asparaginyl-linked oligosaccharides in glycoproteins. Mutually exclusive glycosylation by beta-galactoside alpha2 goes to 6 sialyltransferase and N-acetylglucosaminide alpha1 goes to 3 fucosyltransferase. (1978) (179)
Interactions of Animal Viruses with Cell Surface Receptors (1985) (176)
A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine (2017) (175)
Systematic purification of five glycosidases from Streptococcus (Diplococcus) pneumoniae. (1977) (174)
Ganglioside GM2 as a human tumor antigen (OFA-I-1). (1983) (173)
A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure (2017) (173)
Negative Regulation of T Cell Receptor Signaling by Siglec-7 (p70/AIRM) and Siglec-9* (2004) (171)
Siglecs as Immune Cell Checkpoints in Disease. (2020) (171)
Updates to the Symbol Nomenclature For Glycans (SNFG) Guidelines. (2019) (170)
Tissue-specific expression of sialyltransferases. (1989) (170)
Polymerase chain reaction cloning of a developmentally regulated member of the sialyltransferase gene family. (1993) (168)
Solid-Phase Chemical-Enzymic Synthesis of Glycopeptides and Oligosaccharides (1994) (166)
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate (2020) (165)
Structural Evolution of Glycan Recognition by a Family of Potent HIV Antibodies (2014) (164)
Automatic annotation of matrix‐assisted laser desorption/ionization N‐glycan spectra (2005) (164)
Purification of a Gal beta 1 to 4GlcNAc alpha 2 to 6 sialyltransferase and a Gal beta 1 to 3(4)GlcNAc alpha 2 to 3 sialyltransferase to homogeneity from rat liver. (1982) (163)
Microbial glycan microarrays define key features of host-microbial interactions. (2014) (161)
Hemagglutinin homologue from H17N10 bat influenza virus exhibits divergent receptor-binding and pH-dependent fusion activities (2013) (161)
A focused microarray approach to functional glycomics: transcriptional regulation of the glycome. (2006) (161)
Role of H1 receptors and P-selectin in histamine-induced leukocyte rolling and adhesion in postcapillary venules. (1994) (158)
Sialylation of glycoprotein oligosaccharides N-linked to asparagine. Enzymatic characterization of a Gal beta 1 to 3(4)GlcNAc alpha 2 to 3 sialyltransferase and a Gal beta 1 to 4GlcNAc alpha 2 to 6 sialyltransferase from rat liver. (1982) (158)
Systematic nomenclature for sialyltransferases. (1996) (158)
Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand. (2005) (157)
Primary structure of Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase determined by mass spectrometry sequence analysis and molecular cloning. Evidence for a protein motif in the sialyltransferase gene family. (1992) (155)
Global site-specific N-glycosylation analysis of HIV envelope glycoprotein (2017) (154)
Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact. (2004) (154)
Glycosyltransferases and their use in assessing oligosaccharide structure and structure-function relationships. (1981) (154)
Structural Characterization of the Hemagglutinin Receptor Specificity from the 2009 H1N1 Influenza Pandemic (2011) (154)
Functional Balance of the Hemagglutinin and Neuraminidase Activities Accompanies the Emergence of the 2009 H1N1 Influenza Pandemic (2012) (153)
Covalent display of oligosaccharide arrays in microtiter plates. (2004) (152)
Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes (2010) (152)
Frontiers in glycomics: Bioinformatics and biomarkers in disease An NIH White Paper prepared from discussions by the focus groups at a workshop on the NIH campus, Bethesda MD (September 11–13, 2006) (2008) (152)
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate (2020) (152)
Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis. (2013) (151)
Role of selectins in local and remote tissue injury following ischemia and reperfusion. (1994) (150)
Anti-P-selectin monoclonal antibody attenuates reperfusion injury to the rabbit ear. (1993) (149)
Regulation of alpha 2,3-sialyltransferase expression correlates with conversion of peanut agglutinin (PNA)+ to PNA- phenotype in developing thymocytes. (1993) (148)
Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions. (2012) (146)
Combined chemical and enzymatic synthesis of sialyloligosaccharides and characterization by 500-MHz and proton and carbon-13 NMR spectroscopy (1986) (146)
Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo (2010) (145)
Differential subcompartmentation of terminal glycosylation in the Golgi apparatus of intestinal absorptive and goblet cells. (1986) (143)
Purification and characterization of an O-acetylsialic acid-specific lectin from a marine crab Cancer antennarius. (1985) (142)
High-efficiency synthesis of sialyloligosaccharides and sialoglycopeptides (1990) (141)
Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling (2006) (141)
The N2 neuraminidase of human influenza virus has acquired a substrate specificity complementary to the hemagglutinin receptor specificity. (1991) (138)
Recent H3N2 Viruses Have Evolved Specificity for Extended, Branched Human-type Receptors, Conferring Potential for Increased Avidity. (2017) (138)
Influenza virus hemagglutinins differentiate between receptor determinants bearing N-acetyl-, N-glycollyl-, and N,O-diacetylneuraminic acids. (1985) (134)
Basis for the potent inhibition of influenza virus infection by equine and guinea pig alpha 2-macroglobulin. (1989) (133)
Preferential Recognition of Avian-Like Receptors in Human Influenza A H7N9 Viruses (2013) (132)
Sialylation of glycoprotein oligosaccharides with N-acetyl-, N-glycolyl-, and N-O-diacetylneuraminic acids. (1985) (131)
An Atlas of Human Glycosylation Pathways Enables Display of the Human Glycome by Gene Engineered Cells. (2019) (131)
High-Affinity Ligand Probes of CD22 Overcome the Threshold Set by cis Ligands to Allow for Binding, Endocytosis, and Killing of B Cells1 (2006) (131)
Cloning and expression of the Gal beta 1, 3GalNAc alpha 2,3-sialyltransferase. (1992) (130)
Purification to homogeneity of a beta-galactoside alpha2 leads to 3 sialyltransferase and partial purification of an alpha-N-acetylgalactosaminide alpha2 leads to 6 sialyltransferase from porcine submaxillary glands. (1979) (129)
Restoration of specific myxovirus receptors to asialoerythrocytes by incorporation of sialic acid with pure sialyltransferases. (1979) (128)
A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin (2013) (127)
Transcriptional programs of lymphoid tissue capillary and high endothelium reveal control mechanisms for lymphocyte homing (2014) (127)
Purification of a sialyltransferase from bovine colostrum by affinity chromatography on CDP-agarose. (1977) (126)
Neutrophil adhesion in leukocyte adhesion deficiency syndrome type 2. (1995) (126)
Activation of Murine CD4+ and CD8+ T Lymphocytes Leads to Dramatic Remodeling of N-Linked Glycans1 (2006) (125)
Biosynthesis of mammalian glycoproteins. Glycosylation pathways in the synthesis of the nonreducing terminal sequences. (1979) (125)
Sendai virus utilizes specific sialyloligosaccharides as host cell receptor determinants. (1980) (124)
Distinct Endocytic Mechanisms of CD22 (Siglec-2) and Siglec-F Reflect Roles in Cell Signaling and Innate Immunity (2007) (124)
Cloning and Expression of Human Galβ1,3(4)GlcNAc α2,3-Sialyltransferase (1993) (119)
Recognition of Microbial Glycans by Human Intelectin (2015) (118)
Polyoma virus recognizes specific sialyligosaccharide receptors on host cells. (1981) (118)
A Highly Pathogenic Avian H7N9 Influenza Virus Isolated from A Human Is Lethal in Some Ferrets Infected via Respiratory Droplets. (2017) (118)
Host-mediated selection of influenza virus receptor variants. Sialic acid-alpha 2,6Gal-specific clones of A/duck/Ukraine/1/63 revert to sialic acid-alpha 2,3Gal-specific wild type in ovo. (1985) (115)
Carbohydrate composition and identification of blood group A, B, and H oligosaccharide structures on human Factor VIII/von Willebrand factor. (1979) (115)
Crystal structures of two subtype N10 neuraminidase-like proteins from bat influenza A viruses reveal a diverged putative active site (2012) (115)
The signal anchor and stem regions of the beta-galactoside alpha 2,6-sialyltransferase may each act to localize the enzyme to the Golgi apparatus. (1992) (113)
Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffolds. (2010) (113)
Enzymatic properties of beta-D-galactoside alpha2 leads to 6 sialytransferase from bovine colostrum. (1977) (113)
Influenza Virus Neuraminidases with Reduced Enzymatic Activity That Avidly Bind Sialic Acid Receptors (2012) (112)
The specificity of viral and bacterial sialidases for α(2–3)- and α(2–6)-linked sialic acids in glycoproteins (1983) (112)
Different cell-surface receptor determinants of antigenically similar influenza virus hemagglutinins. (1981) (110)
GlyTouCan: an accessible glycan structure repository. (2017) (109)
Organization of the beta-galactoside alpha 2,6-sialyltransferase gene. Evidence for the transcriptional regulation of terminal glycosylation. (1990) (107)
Conversion of a Golgi apparatus sialyltransferase to a secretory protein by replacement of the NH2-terminal signal anchor with a signal peptide. (1989) (106)
Structure, Receptor Binding, and Antigenicity of Influenza Virus Hemagglutinins from the 1957 H2N2 Pandemic (2009) (106)
Newcastle disease virus contains a linkage-specific glycoprotein sialidase. Application to the localization of sialic acid residues in N-linked oligosaccharides of alpha 1-acid glycoprotein. (1982) (104)
Mutation of the Sialyltransferase S-sialylmotif Alters the Kinetics of the Donor and Acceptor Substrates* (1998) (103)
Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses. (2011) (103)
Enzymatic characterization of beta D-galactoside alpha2 leads to 3 sialyltransferase from porcine submaxillary gland. (1979) (103)
Hepatic receptor that specifically binds oligosaccharides containing fucosyl alpha1 leads to 3 N-acetylglucosamine linkages. (1978) (103)
α2,6-Sialic Acid on Platelet Endothelial Cell Adhesion Molecule (PECAM) Regulates Its Homophilic Interactions and Downstream Antiapoptotic Signaling* (2010) (100)
Ligand Recognition by E-Selectin: Synthesis, Inhibitory Activity and Conformational Analysis of Bivalent Sialyl Lewis x Analogs (1995) (99)
Protective effects of sialylated oligosaccharides in immune complex- induced acute lung injury (1993) (98)
Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer (2018) (98)
MIRAGE: The minimum information required for a glycomics experiment (2014) (97)
Antigen Delivery to Macrophages Using Liposomal Nanoparticles Targeting Sialoadhesin/CD169 (2012) (95)
INHIBITION OF AXOPLASMIC TRANSPORT BY COLCHICINE, PODOPHYLLOTOXIN, AND VINBLASTINE: AN EFFECT ON MICROTUBULES * (1975) (93)
4-O-acetyl-N-acetylneuraminic acid in the N-linked carbohydrate structures of equine and guinea pig alpha 2-macroglobulins, potent inhibitors of influenza virus infection. (1989) (92)
Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation (2013) (92)
Post-Golgi apparatus localization and regional expression of rat intestinal sialyltransferase detected by immunoelectron microscopy with polypeptide epitope-purified antibody. (1988) (92)
Activation and transfer of novel synthetic 9-substituted sialic acids. (1987) (91)
P-selectin and ICAM-1-dependent adherence reactions: role in the genesis of postischemic no-reflow. (1994) (91)
Noninvasive imaging of dendrimer-type N-glycan clusters: in vivo dynamics dependence on oligosaccharide structure. (2010) (91)
Siglecs as sensors of self in innate and adaptive immune responses (2012) (90)
The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen (2018) (90)
Tissue-specific alternative splicing of the beta-galactoside alpha 2,6-sialyltransferase gene. (1992) (88)
The role of sialic acid in the expression of human MN blood group antigens. (1979) (88)
CD22 Is a Recycling Receptor That Can Shuttle Cargo between the Cell Surface and Endosomal Compartments of B Cells (2011) (88)
Mammalian adaptation of influenza A(H7N9) virus is limited by a narrow genetic bottleneck (2015) (88)
Chemoenzymatic synthesis of 2-azidoethyl-ganglio-oligosaccharides GD3, GT3, GM2, GD2, GT2, GM1, and GD1a. (2005) (88)
Receptor Specificity of Influenza A H3N2 Viruses Isolated in Mammalian Cells and Embryonated Chicken Eggs (2010) (83)
Glycan-targeted virus-like nanoparticles for photodynamic therapy. (2012) (82)
Sialoside analogue arrays for rapid identification of high affinity siglec ligands. (2008) (81)
Three mutations switch H7N9 influenza to human-type receptor specificity (2017) (81)
In Vivo Cleavage of α2,6-Sialyltransferase by Alzheimer β-Secretase* (2005) (80)
Identification and expression of Neu4, a novel murine sialidase. (2003) (80)
Circulating avian influenza viruses closely related to the 1918 virus have pandemic potential. (2014) (80)
Kinetic analysis of the influenza A virus HA/NA balance reveals contribution of NA to virus-receptor binding and NA-dependent rolling on receptor-containing surfaces (2018) (79)
Recognition of monovalent sialosides by influenza virus H3 hemagglutinin. (1987) (79)
Regulated expression of alpha 2,6-sialyltransferase by the liver-enriched transcription factors HNF-1, DBP, and LAP. (1992) (77)
Virus recognition of glycan receptors (2019) (77)
Molecular determinants of lipid mediator-induced leukocyte adherence and emigration in rat mesenteric venules. (1994) (77)
The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting glycan microarray-based data (2016) (76)
Clostridium difficile toxin A-induced microvascular dysfunction. Role of histamine. (1994) (76)
Recognition of sialylated poly-N-acetyllactosamine chains on N- and O-linked glycans by human and avian influenza A virus hemagglutinins. (2012) (75)
Effective replication of human influenza viruses in mice lacking a major alpha2,6 sialyltransferase. (2007) (74)
Specificity and Affinity of Sialic Acid Binding by the Rhesus Rotavirus VP8* Core (2002) (73)
Resialylated erythrocytes for assessment of the specificity of sialyloligosaccharide binding proteins. (1987) (73)
Molecular Cloning of a Developmentally Regulated N-Acetylgalactosamine 2,6-Sialyltransferase Specific for Sialylated Glycoconjugates (*) (1996) (73)
P-selectin and TNF inhibition reduce venous thrombosis inflammation. (1996) (72)
Receptor specificity of subtype H1 influenza A viruses isolated from swine and humans in the United States. (2011) (71)
Human melanoma antigen O-acetylated ganglioside GD3 is recognized by Cancer antennarius lectin. (1988) (71)
Colorful virus-like particles: fluorescent protein packaging by the Qβ capsid. (2011) (71)
Efficient chemoenzymatic synthesis of O-linked sialyl oligosaccharides. (2002) (71)
Glycoproteomics enabled by tagging sialic acid- or galactose-terminated glycans. (2013) (70)
Sialyloligosaccharide receptors of binding variants of polyoma virus. (1983) (70)
On-virus construction of polyvalent glycan ligands for cell-surface receptors. (2008) (70)
Systemic Blockade of Sialylation in Mice with a Global Inhibitor of Sialyltransferases* (2014) (70)
Receptor specificity of influenza virus influences severity of illness in ferrets. (1995) (69)
Copresentation of Antigen and Ligands of Siglec-G Induces B Cell Tolerance Independent of CD22 (2013) (67)
Carbohydrate on human factor VIII/von Willebrand factor. Impairment of function by removal of specific galactose residues. (1978) (66)
Potent Glycan Inhibitors of Myelin-associated Glycoprotein Enhance Axon Outgrowth in Vitro* (2005) (65)
A new multi-enzyme system for a one-pot synthesis of sialyl oligosaccharides: Combined use of β-galactosidase and α(26)-sialyltransferase coupled with regeneration in situ of CMP-sialic acid (1993) (65)
Disubstituted Sialic Acid Ligands Targeting Siglecs CD33 and CD22 Associated with Myeloid Leukaemias and B Cell Lymphomas. (2014) (64)
In Situ trans Ligands of CD22 Identified by Glycan-Protein Photocross-linking-enabled Proteomics* (2010) (64)
Genomic Organization and Chromosomal Mapping of the Galβ1,3GalNAc/Galβ1,4GlcNAc α2,3-Sialyltransferase (*) (1996) (63)
A Mass Spectrometry Plate Reader: Monitoring Enzyme Activity and Inhibition with a Desorption/Ionization on Silicon (DIOS) Platform (2004) (63)
Bifunctional CD22 ligands use multimeric immunoglobulins as protein scaffolds in assembly of immune complexes on B cells. (2008) (62)
Hemagglutinin Receptor Specificity and Structural Analyses of Respiratory Droplet-Transmissible H5N1 Viruses (2013) (61)
Click and pick: identification of sialoside analogues for siglec-based cell targeting. (2012) (60)
Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties (2017) (60)
[41] Purification of mammalian glycosyltransferases (1982) (60)
CD33 recruitment inhibits IgE-mediated anaphylaxis and desensitizes mast cells to allergen (2019) (59)
Transfer of synthetic sialic acid analogues to N- and O-linked glycoprotein glycans using four different mammalian sialyltransferases. (1989) (59)
Constitutively unmasked CD22 on B cells of ST6Gal I knockout mice: novel sialoside probe for murine CD22. (2002) (59)
Efficient preparation of natural and synthetic galactosides with a recombinant beta-1,4-galactosyltransferase-/UDP-4'-gal epimerase fusion protein. (2001) (58)
Conserved Cysteines in the Sialyltransferase Sialylmotifs Form an Essential Disulfide Bond* (2001) (58)
Structure, biosynthesis and functions of glycoprotein glycans (1982) (57)
Cardioprotection by liposome-conjugated sialyl Lewisx-oligosaccharide in myocardial ischaemia and reperfusion injury. (1995) (57)
Chemical and enzymatic synthesis of multivalent sialoglycopeptides. (1994) (57)
Antigenic analyses of influenza virus haemagglutinins with different receptor-binding specificities. (1984) (56)
Reduction of rat myocardial ischemia and reperfusion injury by sialyl Lewis x oligosaccharide and anti-rat P-selectin antibodies. (1996) (56)
Global site-specific analysis of glycoprotein N-glycan processing (2018) (56)
The minimum information required for a glycomics experiment (MIRAGE) project: sample preparation guidelines for reliable reporting of glycomics datasets. (2016) (56)
Microtubules and axoplasmic transport. (1974) (55)
Conformational analysis of sialyloligosaccharides. (1991) (55)
CD22 Regulates Adaptive and Innate Immune Responses of B Cells (2010) (54)
In silico-aided design of a glycan ligand of sialoadhesin for in vivo targeting of macrophages. (2012) (54)
A human-infecting H10N8 influenza virus retains a strong preference for avian-type receptors. (2015) (54)
Cluster sialoside inhibitors for influenza virus: synthesis, NMR, and biological studies. (1992) (54)
H5N1 receptor specificity as a factor in pandemic risk. (2013) (54)
Use of sialic acid analogues to define functional groups involved in binding to the influenza virus hemagglutinin. (1992) (52)
Microtubules and axoplasmic transport. Inhibition of transport by podophyllotoxin: an interaction with microtubule protein (1975) (51)
A phenotype survey of 36 mutant mouse strains with gene-targeted defects in glycosyltransferases or glycan-binding proteins. (2013) (50)
Thrombin receptor peptide-mediated leukocyte rolling in rat mesenteric venules: roles of P-selectin and sialyl Lewis X. (1994) (50)
On-chip synthesis and screening of a sialoside library yields a high affinity ligand for Siglec-7. (2013) (49)
Probing the binding specificities of human Siglecs by cell-based glycan arrays (2021) (48)
Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis (2007) (48)
A complex epistatic network limits the mutational reversibility in the influenza hemagglutinin receptor-binding site (2018) (47)
Clostridium difficile Toxin A-induced Microvascular Dysfunction (1994) (46)
High-throughput screening for inhibitors of sialyl- and fucosyltransferases. (2011) (46)
T cells control the generation of nanomolar-affinity anti-glycan antibodies (2017) (46)
Differential infection of receptor-modified host cells by receptor-specific influenza viruses. (1985) (46)
Reactivation of asialo-rabbit liver binding protein by resialylation with beta-D-galactoside alpha2 leads to 6 sialyltransferase. (1977) (45)
Targeted Delivery of Mycobacterial Antigens to Human Dendritic Cells via Siglec-7 Induces Robust T Cell Activation (2014) (45)
Highly Pathogenic Influenza A(H5Nx) Viruses with Altered H5 Receptor-Binding Specificity (2017) (45)
CD22 Ligands on a Natural N-Glycan Scaffold Efficiently Deliver Toxins to B-Lymphoma Cells. (2017) (44)
Siglecs Induce Tolerance to Cell Surface Antigens by BIM-Dependent Deletion of the Antigen-Reactive B Cells (2014) (43)
A synthetic sialic acid analogue is recognized by influenza C virus as a receptor determinant but is resistant to the receptor-destroying enzyme. (1992) (43)
Peanut Agglutinin High Phenotype of Activated CD8+ T Cells Results from de Novo Synthesis of CD45 Glycans* (2004) (43)
Visualization of the HIV-1 Env glycan shield across scales (2019) (42)
Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase Antibodies. (2019) (42)
A Unique and Conserved Neutralization Epitope in H5N1 Influenza Viruses Identified by an Antibody against the A/Goose/Guangdong/1/96 Hemagglutinin (2013) (42)
In vivo cleavage of alpha2,6-sialyltransferase by Alzheimer beta-secretase. (2005) (42)
Phage-display selection of a human single-chain fv antibody highly specific for melanoma and breast cancer cells using a chemoenzymatically synthesized G(M3)-carbohydrate antigen. (2002) (42)
Synthesis of biologically active N- and O-linked glycans with multisialylated poly-N-acetyllactosamine extensions using P. damsela α2-6 sialyltransferase. (2013) (42)
Evolution of the Hemagglutinin Protein of the New Pandemic H1N1 Influenza Virus: Maintaining Optimal Receptor Binding by Compensatory Substitutions (2013) (41)
Mechanistic Investigation and Multiplexing of Liposome-Assisted Metabolic Glycan Labeling. (2018) (41)
Structure and receptor binding of the hemagglutinin from a human H6N1 influenza virus. (2015) (41)
Polyoma virus adsorbs to specific sialyloligosaccharide receptors on erythrocytes. (1980) (41)
Transitional and marginal zone B cells have a high proportion of unmasked CD22: implications for BCR signaling. (2003) (41)
Diversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin. (2017) (40)
The interaction of colchicine and some related alkaloids with rat brain tubulin. (1977) (40)
Co-evolution of HIV Envelope and Apex-Targeting Neutralizing Antibody Lineage Provides Benchmarks for Vaccine Design (2018) (40)
A single mutation in Taiwanese H6N1 influenza hemagglutinin switches binding to human‐type receptors (2017) (39)
Sialylated keratan sulfate proteoglycans are Siglec-8 ligands in human airways (2018) (39)
Human monoclonal antibody against ganglioside GD2: use in development of enzyme-linked immunosorbent assay for the monitoring of anti-GD2 in cancer patients. (1984) (39)
Synthesis of cluster sialoside inhibitors for influenza virus (1991) (38)
Chemically defined sialoside scaffolds for investigation of multivalent interactions with sialic acid binding proteins. (2003) (37)
Repression of phagocytosis by human CD33 is not conserved with mouse CD33 (2019) (37)
Adaptation of influenza viruses to human airway receptors (2020) (36)
Codistribution of galactosyl- and sialyltransferase: reorganization of trans Golgi apparatus elements in hepatocytes in intact liver and cell culture. (1987) (36)
Helicobacter pylori β1,3-N-acetylglucosaminyltransferase for versatile synthesis of type 1 and type 2 poly-LacNAcs on N-linked, O-linked and I-antigen glycans. (2012) (36)
Preventing an Antigenically Disruptive Mutation in Egg-Based H3N2 Seasonal Influenza Vaccines by Mutational Incompatibility (2019) (35)
Cloning and expression of human Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase. (1993) (35)
Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22 (2012) (35)
Chemical‐Enzymatic Synthesis and Conformational Analysis of Sialyl Lewis x and Derivatives. (1993) (34)
Unmasking of CD22 Co-receptor on Germinal Center B-cells Occurs by Alternative Mechanisms in Mouse and Man* (2015) (34)
Biosynthesis of a disialylated sequence in N-linked oligosaccharides: identification of an N-acetylglucosaminide (alpha 2----6)-sialyltransferase in Golgi apparatus from rat liver. (1984) (34)
Frontiers in Glycomics; Bioinformatics and Biomarkers in Disease September 11‐13, 2006 Natcher Conference Center, NIH Campus, Bethesda, MD, USA (2007) (34)
Selection of influenza virus variants based on sialyloligosaccharide receptor specificity (1984) (34)
Novel Receptor Specificity of Avian Gammacoronaviruses That Cause Enteritis (2015) (34)
A novel strategy for synthesis of ganglioside GM3 using an enzymically produced sialoside glycosyl donor (1993) (33)
Mutation of the Second Sialic Acid-Binding Site, Resulting in Reduced Neuraminidase Activity, Preceded the Emergence of H7N9 Influenza A Virus (2017) (33)
The 150-Loop Restricts the Host Specificity of Human H10N8 Influenza Virus. (2017) (32)
Targeted Delivery of Antigen to Activated CD169+ Macrophages Induces Bias for Expansion of CD8+ T Cells. (2019) (32)
The specificity of viral and bacterial sialidases for alpha(2-3)- and alpha(2-6)-linked sialic acids in glycoproteins. (1983) (32)
Bacterial Polysaccharide Specificity of the Pattern Recognition Receptor Langerin Is Highly Species-dependent* (2016) (32)
Large-scale expression of recombinant sialyltransferases and comparison of their kinetic properties with native enzymes (1995) (31)
Exploiting CD22 on antigen-specific B cells to prevent allergy to the major peanut allergen Ara h 2. (2017) (31)
In vivo tropism of Salmonella Typhi toxin to cells expressing a multiantennal glycan receptor (2018) (31)
Amino acid residues at positions 222 and 227 of the hemagglutinin together with the neuraminidase determine binding of H5 avian influenza viruses to sialyl Lewis X (2016) (31)
Complete primary structure of porcine tenascin. Detection of tenascin transcripts in adult submaxillary glands. (1991) (31)
Reconstitution of the masking effect of sialic acid groups on sialidase-treated erythrocytes by the action of sialyltransferases. (1986) (30)
P-selectin blockade does not impair leukocyte host defense against bacterial peritonitis and soft tissue infection in rabbits. (1993) (30)
In vitro pharmacological selectivity profile of oseltamivir prodrug (Tamiflu) and active metabolite. (2010) (30)
Encapsulating an Immunosuppressant Enhances Tolerance Induction by Siglec‐Engaging Tolerogenic Liposomes (2017) (30)
Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells (2021) (30)
Characterization of a Feline Influenza A(H7N2) Virus (2018) (30)
CD22-antagonists with nanomolar potency: the synergistic effect of hydrophobic groups at C-2 and C-9 of sialic acid scaffold. (2011) (29)
Leukocyte adhesion deficiency (LAD) II: a new adhesion defect due to absence of sialyl Lewis X, the ligand for selectins. (1993) (29)
Clinical significance of ST3Gal IV expression in human renal cell carcinoma. (2002) (29)
The influence of carbohydrate on the antigenicity of the envelope glycoprotein of avian myeloblastosis virus and B77 avian sarcoma virus. (1978) (29)
Fluorescent Trimeric Hemagglutinins Reveal Multivalent Receptor Binding Properties. (2019) (28)
A sulfonamide sialoside analog for targeting Siglec-8 and -F on im-mune cells. (2019) (28)
Structure and dynamics of the sialic acid moiety of GM3-ganglioside at the surface of a magnetically oriented membrane. (1993) (28)
Expression of β-galactoside α2,6 sialyltransferase blocks synthesis of polysialic acid in Xenopus embryos (1990) (27)
Biocatalytic Preparation of N‐Glycolylneuraminic Acid, Deaminoneuraminic Acid (KDN) and 9‐Azido‐9‐deoxysialic Acid Oligosaccharides (2003) (27)
A monoclonal antibody to P-selectin ameliorates injury associated with hemorrhagic shock in rabbits. (1994) (27)
Human CD22 Inhibits Murine B Cell Receptor Activation in a Human CD22 Transgenic Mouse Model (2017) (27)
Innate Immune Response Triggers Lupus-like Autoimmune Disease (2007) (27)
Synthetic oligosaccharides related to group B streptococcal polysaccharides. 5. Combined chemical and enzymic synthesis of a pentasaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus and one- and two-dimensional NMR spectroscopic studies (1991) (27)
Multivalent ligands for siglecs. (2010) (26)
Flexibility In Vitro of Amino Acid 226 in the Receptor-Binding Site of an H9 Subtype Influenza A Virus and Its Effect In Vivo on Virus Replication, Tropism, and Transmission (2018) (25)
Siglec-F is a novel intestinal M cell marker (2016) (25)
The membrane-binding domain of a rat liver Golgi sialyltransferase. (1987) (24)
Glycoengineering of NK cells with glycan ligands of CD22 and selectins for B-cell lymphoma therapy (2020) (24)
Combined use of trans-sialidase and sialyltransferase for enzymatic synthesis of .alpha.NeuAc2.fwdarw.3.beta.Gal-OCH2CH2SiMe3 (1993) (24)
Nanoparticles Displaying Allergen and Siglec-8 Ligands Suppress IgE-FcεRI–Mediated Anaphylaxis and Desensitize Mast Cells to Subsequent Antigen Challenge (2021) (23)
Exploiting CD22 To Selectively Tolerize Autoantibody Producing B-Cells in Rheumatoid Arthritis. (2019) (22)
A vital sugar code for ricin toxicity (2017) (21)
Structure and Receptor Binding Specificity of Hemagglutinin H13 from Avian Influenza A Virus H13N6 (2013) (21)
Identification of Stabilizing Mutations in an H5 Hemagglutinin Influenza Virus Protein (2015) (21)
Comment on: concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza. (2008) (21)
Salmonella Typhoid Toxin PltB Subunit and Its Non-typhoidal Salmonella Ortholog Confer Differential Host Adaptation and Virulence. (2020) (21)
Custom microarray for glycobiologists: considerations for glycosyltransferase gene expression profiling. (2002) (20)
Avenues to Characterize the Interactions of Extended N‐Glycans with Proteins by NMR Spectroscopy: The Influenza Hemagglutinin Case (2018) (19)
Genetically encoded multivalent liquid glycan array displayed on M13 bacteriophage (2021) (19)
Sialyl Lewisx-containing oligosaccharide exerts beneficial effects in murine traumatic shock. (1994) (19)
SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection. (2021) (17)
Chemo-enzymatic synthesis of a branching decasaccharide fragment of the capsular polysaccharide of type III group B Streptococcus (1991) (17)
O-acetylsialic acid-specific lectin from the crab Cancer anntenarius. (1987) (17)
Site-specific O-glycosylation analysis of SARS-CoV-2 spike protein produced in insect and human cells (2021) (17)
Diversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin. (2017) (17)
Glycan terminator (2009) (16)
Glycan fingerprints: calculating diversity in glycan libraries. (2012) (16)
Enhanced Human-Type Receptor Binding by Ferret-Transmissible H5N1 with a K193T Mutation (2018) (16)
Migration-based selections of antibodies that convert bone marrow into trafficking microglia-like cells that reduce brain amyloid β (2018) (16)
High affinity sialoside ligands of myelin associated glycoprotein. (2011) (16)
Leukocyte adhesion deficiency (LAD) II. (1995) (16)
Combined Chemical and Enzymatic Synthesis of Sialyloligosaccharides and Characterization by 500-MHz1H and13C NMR Spectroscopy. (1986) (16)
Erratum: Diversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin (Cell Host & Microbe (2017) 21(6) (742–753.e8) (S1931312817302044)(10.1016/j.chom.2017.05.011)) (2017) (16)
Synthesis of linkage-specific sialoside substrates for colorimetric assay of neuraminidases. (1991) (16)
Human Influenza Virus Hemagglutinins Contain Conserved Oligomannose N-Linked Glycans Allowing Potent Neutralization by Lectins (2020) (15)
A Siglec-like sialic-acid-binding motif revealed in an adenovirus capsid protein. (2012) (14)
Spatiotemporal expression patterns of sialoglycoconjugates during nephron morphogenesis and their regional and cell type-specific distribution in adult rat kidney (2003) (14)
Immunology: glyco-engineering 'super-self'. (2014) (14)
Potential for Low-Pathogenic Avian H7 Influenza A Viruses To Replicate and Cause Disease in a Mammalian Model (2016) (14)
Inhibition of axoplasmic transport by mescaline and other trimethoxyphenylalkylamines. (1973) (14)
Repression of phagocytosis by human CD33 is not conserved with mouse CD33 (2019) (14)
Proximity Ligation-Based Fluorogenic Imaging Agents for Neuraminidases. (2018) (14)
Genomic organization and chromosomal mapping of the Gal beta 1,3GalNAc/Gal beta 1,4GlcNAc alpha 2,3-sialyltransferase. (1996) (13)
Sialic Acid Ligands of CD28 Suppress Costimulation of T Cells (2021) (13)
Identification of a Gal beta 1 goes to 3GlcNAc alpha 2 goes to 3 sialyltransferase in rat liver. (1982) (13)
Hemagglutinin Traits Determine Transmission of Avian A/H10N7 Influenza Virus between Mammals. (2020) (12)
Carbohydrate moieties as vaccine candidates: targeting the sweet spot in the immune response. (2012) (12)
Unique Structural Features of Influenza Virus H15 Hemagglutinin (2017) (12)
Modulation of Siglec-7 Signaling Via In Situ-Created High-Affinity cis-Ligands (2021) (12)
Diversity of Influenza A(H5N1) Viruses in Infected Humans, Northern Vietnam, 2004–2010 (2018) (12)
Plasticity of Amino Acid Residue 145 Near the Receptor Binding Site of H3 Swine Influenza A Viruses and Its Impact on Receptor Binding and Antibody Recognition (2018) (12)
A Miniaturized Glycan Microarray Assay for Assessing Avidity and Specificity of Influenza A Virus Hemagglutinins. (2016) (11)
Supramolecular complexing of membane Siglec CD22 mediated by a polyvalent heterobifunctional ligand that templates on IgM. (2011) (11)
Antigenic and virological properties of an H3N2 variant that continues to dominate the 2021–22 Northern Hemisphere influenza season (2022) (11)
Complete metal ion requirement of influenza virus N1 neuraminidases (2005) (11)
A novel and efficient synthesis of neolacto series gangliosides 3'-nLM1 and 6'-nLM1 (1994) (11)
Use of a sialic acid analogue to analyze the importance of the receptor-destroying enzyme for the interaction of influenza C virus with cells. (1990) (10)
Sweet inhibitor DAMPens sepsis (2011) (10)
ErratumErratum to “In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity” [Virology 422 (2011) 105–113] (2012) (10)
Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer (2018) (10)
Activation of Murine CD 4 and CD 8 T Lymphocytes Leads to Dramatic Remodeling of N-Linked Glycans 1 (2006) (10)
Human Disease Glycomics/Proteome Initiative Workshop and the 4th HUPO Annual Congress (2006) (9)
Purification of mammalian glycosyltransferases. (1982) (9)
Tolerogenic Nanoparticles Impacting B and T Lymphocyte Responses Delay Autoimmune Arthritis in K/BxN Mice. (2021) (9)
Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens (2018) (9)
Changes to the dynamic nature of hemagglutinin and the emergence of the 2009 pandemic H1N1 influenza virus (2015) (8)
The lack of correlation between hallucinogenesis and inhibition of axoplasmic transport. (1974) (7)
Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo (2010) (7)
DIFFERENT SIALYLOLIGOSACCHARIDE RECEPTOR DETERMINANTS OF ANTIGENICALLY RELATED INFLUENZA VIRUS HEMAGGLUTININS (1981) (6)
The Third ACGG-DB Meeting Report: Towards an international collaborative infrastructure for glycobioinformatics. (2013) (5)
Phenotypic Effects of Substitutions within the Receptor Binding Site of Highly Pathogenic Avian Influenza H5N1 Virus Observed during Human Infection (2020) (5)
Suppressing Immune Responses Using Siglec Ligand-Decorated Anti-receptor Antibodies. (2022) (5)
DeGlyPHER: An Ultrasensitive Method for the Analysis of Viral Spike N-Glycoforms. (2021) (5)
Efficient Chemoenzymatic Synthesis of N‐Glycans with a β1,4‐Galactosylated Bisecting GlcNAc Motif (2020) (5)
Genetically Encoded, Multivalent Liquid Glycan Array (LiGA) (2020) (5)
High‐Efficiency Synthesis of Sialyloligosaccharides and Sialoglycopeptides. (1991) (5)
Antigenic and virological properties of an H3N2 variant that will likely dominate the 2021-2022 Northern Hemisphere influenza season (2021) (4)
198; ROLE OF SELECTINS IN LOCAL, and REMOTE INJURY FOLLOWING ISCHEMIA, and REPERFUSION (1994) (4)
Sialic acid ligands of CD28 block co-stimulation of T cells (2021) (3)
Purification and Characterization of Two Sialyltransferase Activities from Porcine Submaxillary Glands (1979) (3)
Modulation of Siglec-7 Signaling via in situ Created High-affinity cis-Ligands (2020) (3)
Carbohydrate ligands of leukocyte adhesion molecules and their therapeutic potential. (1994) (3)
Modulation of immune responses by targeting CD169/Siglec-1 with the glycan ligand (2011) (3)
CD18 BUT NOT P-SELECTIN BLOCKADE INCREASES INCIDENCE AND SEVERITY OF SUBCUTANEOUS E COLI ABSCESS FORMATION (1993) (3)
Recognition of sialylated poly-LacNAc on N - and O -linked glycans by human and avian influenza A virus hemagglutinins** (2012) (2)
Siglec-Engaging Tolerance-Inducing Antigenic Liposomes (STALs) in the Prevention of Peanut Allergy (2016) (2)
Program and abstracts for the 2012 Joint Meeting of the Society for Glycobiology & American Society for Matrix Biology (2012) (2)
SELECTION OF RECEPTOR VARIANTS FROM HUMAN AND AVIAN INFLUENZA ISOLATES WITH THE H3 HEMAGGLUTININ (1984) (2)
Antibiotic therapy determines subcutaneous Escherichia coli abscess formation after CD18 inhibition in rabbits. (1998) (2)
Program and abstracts for the 2012 Joint Meeting of the Society for Glycobiology & American Society for Matrix Biology (2012) (2)
Coordinated changes in glycosylation regulate the germinal center through CD22 (2021) (2)
Use of Glycosyltransferases and Glycosidases in Structural Analysis of Oligosaccharides (1979) (2)
Improvement of Lipoplexes With a Sialic Acid Mimetic to Target the C1858T PTPN22 Variant for Immunotherapy in Endocrine Autoimmunity (2022) (2)
Author Correction: Repression of phagocytosis by human CD33 is not conserved with mouse CD33 (2020) (1)
Research of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes (2010) (1)
SIALYLOLIGOSACCHARIDE RECEPTOR SPECIFICITY (1984) (1)
Site-Speciﬁc O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells (2021) (1)
Suppression of Autoimmune Rheumatoid Arthritis with Hybrid Nanoparticles That Induce B and T Cell Tolerance to Self-Antigen. (2022) (1)
Receptor Specificity of Influenza A H3N2 Viruses Isolated in Mammalian Cells and Embryonated Chicken Eggs (2010) (1)
Using Siglec-engaging Tolerance-inducing Antigenic Liposomes (STALs) to reduce memory B cell responses to the major peanut allergen Ara h 2 (2018) (1)
Genetically encoded multivalent liquid glycan array displayed on M13 bacteriophage (2022) (1)
Separation of Gal beta 1,4GlcNAc alpha-2,6- and Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferases by affinity chromatography. (1994) (1)
Detection and Quantitation of Drug-Induced Inhibition of Rapid Axoplasmic Transport: Microtubules and Axoplasmic Transport (1974) (1)
Tolerogenic Nanoparticles Impacting B and T Lymphocyte Responses Delay Autoimmune Arthritis in K/BxN Mice (2020) (1)
Author Correction: In vivo tropism of Salmonella Typhi toxin to cells expressing a multiantennal glycan receptor (2019) (1)
Receptors on hepatocytes that bind ligands containing fucosyl alpha 1,3 N-acetylglucosamine linkages. (1980) (1)
Hemagglutinin Traits Determine Transmission of Avian A/H10N7 Virus between Mammals (2020) (1)
Receptors on hepatocytes that bind ligands containing fucosyl α1,3 N-acetylglucosamine linkages (1980) (1)
Chapter 13 Leukocyte adhesion deficiency Type II (1996) (1)
Enhancement of Gene Knockdown on CD22-Expressing Cells by Chemically Modified Glycan Ligand-siRNA Conjugates. (2022) (1)
Unmasking of CD22 on germinal center B-cells occurs by alternative mechanisms in mouse and man (2015) (1)
Host Adaptations of the Salmonella Typhi Typhoid Toxin and Its Orthologue from a Nontyphoidal Salmonella (2019) (1)
Letters to the Glyco-Forum Systematic nomenclature for sialyltransferases (2005) (1)
Temperature dependence for reversion to wild type of SAα2,6Ga1-specific receptor variants of A/duck/Ukraine/1/63 in ovo (1985) (1)
Synthesis of 9‐Substituted Sialic Acids as Probes for CD22‐Ligand Interactions on B Cells (2008) (1)
Homo-multimeric complexes of CD22 in B cells revealed by protein-carbohydrate crosslinking (2005) (1)
Linked Glycans N of Lymphocytes Leads to Dramatic Remodeling T + and CD 8 + Activation of Murine CD 4 (2006) (0)
Recent H 3 N 2 Viruses Have Evolved Specificity for Extended , Branched Human-type Receptors , Conferring Potential for Increased Avidity Graphical (0)
CD22-ligand interactions in BCR signaling (2005) (0)
Multivalent ligands of CD22 for targeting of B cells (2009) (0)
CD 33 recruitment inhibits IgE-mediated anaphylaxis and 1 desensitizes mast cells to allergen 2 3 (2019) (0)
Induces Robust T Cell Activation to Human Dendritic Cells via Siglec-7 Targeted Delivery of Mycobacterial Antigens (2014) (0)
Compositions et methode pour l'identification et la synthese de sialyltransferases (1993) (0)
Decision letter: POMK regulates dystroglycan function via LARGE1-mediated elongation of matriglycan (2020) (0)
Repertoire / Diversity (T and B) (SY3-3) Chairpersons: Masamichi Muramatsu, Kristin Hogquist (2010) (0)
Siglec induction of B cell tolerance by recognition of sialic acids as self (359.1) (2014) (0)
Antigen-Reactive B Cells Antigens by BIM-Dependent Deletion of the Siglecs Induce Tolerance to Cell Surface (2014) (0)
Altered glycosylation of cancer cells confers phenotypic changes that promote spread and evasion of immune responses. A new method for engineering cell surface glycans is providing insights into these mechanisms. (2014) (0)
Isolation and characterization of glycosyl transferases. (1977) (0)
Supporting Information for Proteomics DOI 10.1002/pmic.200700917 (2007) (0)
Antigenic and molecular variation in subpopulations of influenza viruses isolated from an infected individual in different host cells (1988) (0)
Endosomal Compartments of B Cells Shuttle Cargo between the Cell Surface and CD22 Is a Recycling Receptor That Can (2010) (0)
Expression of beta-galactoside alpha 2,6 sialyltransferase blocks synthesis of polysialic acid in Xenopus embryos. (1990) (0)
, A / Goose / Guangdong / 1 / 96 Hemagglutinin by an Antibody against the IdentifiedEpitope in H 5 N 1 Influenza Viruses A Unique and Conserved Neutralization (2013) (0)
Sialoside probes of siglec-ligand interactions (2005) (0)
Cover Picture: A Mass Spectrometry Plate Reader: Monitoring Enzyme Activity and Inhibition with a Desorption/Ionization on Silicon (DIOS) Platform (ChemBioChem 7/2004) (2004) (0)
S2.5 Cloning of novel genes related to the sialyltransferase gene family (1993) (0)
Possible Misidentification of Mycobacterium yongonense (2014) (0)
A role for underlying glycan structure in influenza binding: extending the species specificity paradigm (2016) (0)
Author Correction: In vivo tropism of Salmonella Typhi toxin to cells expressing a multiantennal glycan receptor (2019) (0)
Receptor Speciﬁcity of Inﬂuenza A H3N2 Viruses Isolated in Mammalian Cells and Embryonated Chicken Eggs (cid:1) (2010) (0)
Glycosylation Pathways in Glycoprotein Biosynthesis (2002) (0)
Newcastle Disease Virus Contains a Linkage-specific Glycoprotein Sialidase APPLICATION TO THE LOCALIZATION OF SIALIC ACID RESIDUES IN N-LINKED OLIGOSACCHARIDES OF al-ACID GLYCOPROTEIN* (2001) (0)
Sterol Regulation of Metabolism , Homeostasis , and Development (2017) (0)
Human IgE monoclonal antibodies define the molecular basis of red meat allergy (2021) (0)
A Virus H 13 N 6 of Hemagglutinin H 13 from Avian Influenza Structure and Receptor Binding Specificity (2013) (0)
Compositions et methodes pour l'obtention de sialyltransferases (1994) (0)
Pathogen array reveals innate immune defense against molecular mimicry (112.16) (2012) (0)
An ultrasensitive method for analysis of viral spike N-glycoforms (2021) (0)
S8.1 Selectins, sialosides, and sialyltransferases (1993) (0)
Author Correction: Repression of phagocytosis by human CD33 is not conserved with mouse CD33 (2020) (0)
Synthesis of sialoside analogs useful for exploring Siglec biology (2006) (0)
Oligosaccharide Structures on Human Factor VIII / Van Willebrand Factor * (2002) (0)
In vivo tropism of Salmonella Typhi toxin to cells expressing a multiantennal glycan receptor (2017) (0)
Microarray for glycobiologists: analysis of cellular glycosylation changes (2002) (0)
Incorporation and detection of 9-substituted Neu5Ac derivatives on cell surface (2004) (0)
A complex epistatic network limits the mutational reversibility in the influenza hemagglutinin receptor-binding site (2018) (0)
A structural explanation for the low efficacy of the seasonal influenza H3N2 vaccine (2017) (0)
Abstract #5378: B cell depletion therapy with cytotoxic liposomes containing glycan ligands of CD22: A novel strategy for treatment of human B cell lymphoma (2009) (0)
Intercellular adhesion promoting agents (1992) (0)
Table of Contents (1991) (0)
Amino acid residues at positions 222 and 227 of the hemagglutinin together with the neuraminidase determine binding of H5 avian influenza viruses to sialyl Lewis X (2015) (0)
GLYCOSYL TRANSFERASES IN OLIGOSACCHARIDE BIOSYNTHESIS AND THEIR USE IN STRUCTURE - FUNCTION ANALYSIS OF GLYCOPROTEINS (1980) (0)
A New Multi-Enzyme System for a One-Pot Synthesis of Sialyl Oligosaccharides: Combined Use of β-Galactosidase and α(2,6) -Sialyltransferase Coupled with Regeneration in situ of CMP-Sialic Acid. (2010) (0)
Recognition of sialoglycoconjugates by a macrophage cell interaction molecule (1990) (0)
P-selectin antibodies and their use (1995) (0)
ResponsesInduce Specific High Titer IgG Antibody Carbohydrate B Cell Epitope Conjugates Linear PADRE T Helper Epitope and (2000) (0)
Title Mammalian adaptation of influenza A ( H 7 N 9 ) virus is limited by anarrow genetic bottleneck (0)
Efficient lipid antigen presentation to NKT cells by targeting CD169/Siglec-1 on macrophages with its glycan ligand. (100.49) (2011) (0)
Resource An Atlas of Human Glycos ylation Pathways Enables Display of the Human Glycome by Gene Engineered Cells Graphical Abstract Highlights (2019) (0)
Bioinformatics Approach for Functional Glycomics (2007) (0)
linking enabled proteomics (2010) (0)
Robert L. Hill, 1928–2012 (2013) (0)
Method for production of secretable glycosyltransferases (1990) (0)
Symposium on structure, function and evolution of glycoproteins and related molecules. Dedicated to Robert L. Hill to commemorate his 65th birthday. Orcas Island, Washington, August 16-19, 1995. (1996) (0)
Leukocyte Adhesion and Vascular Protein Leakage (2005) (0)
Harnessing Siglecs to Induce Immune Tolerance (2017) (0)
PLOS Pathogens 2017 Reviewer and Editorial Board Thank You (2018) (0)
Tribute to Sen-itiroh Hakomori (2022) (0)
Consortium for Functional Glycomics Overview (2007) (0)
A Novel and Efficient Synthesis of Neolacto Series Gangliosides 3′‐ nLM1 and 6′‐nLM1. (1994) (0)
Sialylation practiced in vitro of recombinant glycoproteins. (1998) (0)
Studies on the Structure and Activities of Influenza Virus Haemagglutinin (1984) (0)
Induction of antigen-specific B cell tolerance through the development of a versatile platform to target siglecs (2011) (0)
The 150-Loop Restricts th e Host Specificity of Human H 10 N 8 Influenza Virus Graphical Abstract Highlights (0)

This paper list is powered by the following services:

Other Resources About James C. Paulson

en.wikipedia.org

What Schools Are Affiliated With James C. Paulson?

James C. Paulson is affiliated with the following schools:

James C. Paulson's Academic­Influence.com Rankings